| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $204.7M | +37.6% |
| Cost of Revenue | $56.1M | +49.8% |
| Gross Profit | $148.6M | +33.6% |
| R&D Expense | $11.0M | +8.2% |
| SG&A Expense | $102.8M | +36.3% |
| Operating Income | -$35.0M | -30.9% |
| Interest Expense | $35K | -16.7% |
| Pre-tax Income | -$41.9M | -96.7% |
| Income Tax | -$4.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.8M | +41.1% |
| Short-term Investments | $25.0M | -49.2% |
| Accounts Receivable | $42.4M | +22.4% |
| Inventory | $117.0M | +10.5% |
| Current Assets | $237.2M | +4.7% |
| Total Assets | $473.2M | +7.9% |
| Current Liabilities | $34.0M | -18.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.0M | -0.0% |
| Capital Expenditures | $14.3M | -15.5% |
| Investing Cash Flow | -$13.2M | -131.6% |
| Financing Cash Flow | $53.1M | +627.8% |
| Free Cash Flow | -$41.3M | +5.9% |
| -1115.1% |
| Net Income | -$37.8M | -80.3% |
| EPS (Basic) | -$1.64 | -78.3% |
| EPS (Diluted) | -$1.64 | -78.3% |
| Long-term Debt |
| $77.5M |
| +600.4% |
| Total Liabilities | $118.6M | +92.2% |
| Stockholders' Equity | $354.6M | -6.0% |